Your browser doesn't support javascript.
loading
Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation.
Wang, Zhoufeng; Xie, Kehui; Zhu, Guonian; Ma, Chengcheng; Cheng, Cheng; Li, Yangqian; Xiao, Xue; Li, Chengpin; Tang, Jun; Wang, Hui; Su, Zhixi; Liu, Dan; Zhang, Wengeng; Huang, Yan; Tang, Huairong; Liu, Rui; Li, Weimin.
Afiliação
  • Wang Z; Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Xie K; Singlera Genomics (Shanghai) Ltd, Shanghai, China.
  • Zhu G; Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Ma C; Singlera Genomics (Shanghai) Ltd, Shanghai, China.
  • Cheng C; Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Li Y; Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Xiao X; Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Li C; Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Tang J; Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Wang H; Singlera Genomics (Shanghai) Ltd, Shanghai, China.
  • Su Z; Singlera Genomics (Shanghai) Ltd, Shanghai, China.
  • Liu D; Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhang W; Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Huang Y; Health Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Tang H; Health Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Liu R; Singlera Genomics (Shanghai) Ltd, Shanghai, China. rliu@singleragenomics.com.
  • Li W; Department of Respiratory and Critical Care Medicine, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China. weimi003@scu.edu.cn.
Respir Res ; 24(1): 163, 2023 Jun 17.
Article em En | MEDLINE | ID: mdl-37330511
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude Assunto principal: DNA Tumoral Circulante / Pneumopatias / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude Assunto principal: DNA Tumoral Circulante / Pneumopatias / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China